These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 23100567

  • 21. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
    De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.
    J Acquir Immune Defic Syndr; 2012 Mar 01; 59(3):236-44. PubMed ID: 22327246
    [Abstract] [Full Text] [Related]

  • 22. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.
    Antivir Ther; 2003 Oct 01; 8(5):379-84. PubMed ID: 14640384
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
    Paton NI, Sangeetha S, Earnest A, Bellamy R.
    HIV Med; 2006 Jul 01; 7(5):323-30. PubMed ID: 16945078
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G, Fink V, Koethe JR, Giganti MJ, Jayathilake K, Blevins M, Cahn P, Grinsztejn B, Wolff M, Pape JW, Padgett D, Madero JS, Gotuzzo E, McGowan CC, Shepherd BE.
    J Int AIDS Soc; 2015 Jul 01; 18(1):20016. PubMed ID: 26165322
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, Keiser O, IeDEA Southern Africa.
    Trop Med Int Health; 2012 Dec 01; 17(12):1509-20. PubMed ID: 22994151
    [Abstract] [Full Text] [Related]

  • 35. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.
    Bekker LG, Myer L, Orrell C, Lawn S, Wood R.
    S Afr Med J; 2006 Apr 01; 96(4):315-20. PubMed ID: 16670804
    [Abstract] [Full Text] [Related]

  • 36. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
    Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, Dabis F, Nash D, Sinayobye JD, Niyongabo T, Tanon A, Poda A, Adedimeji AA, Edmonds A, Davies MA, Egger M, African regions of the International epidemiologic Databases to Evaluate AIDS (IeDEA).
    J Int AIDS Soc; 2018 Feb 01; 21(2):. PubMed ID: 29479867
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis.
    Hamers RL, Sawyer AW, Tuohy M, Stevens WS, Rinke de Wit TF, Hill AM, ART-A Consortium.
    AIDS; 2012 Aug 24; 26(13):1663-72. PubMed ID: 22695297
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.
    Marazzi MC, De Luca S, Palombi L, Scarcella P, Ciccacci F, Ceffa S, Nielsen-Saines K, De Luca A, Mancinelli S, Gennaro E, Zimba I, Liotta G, Buonomo E.
    Pediatr Infect Dis J; 2014 Mar 24; 33(3):295-300. PubMed ID: 23799517
    [Abstract] [Full Text] [Related]

  • 40. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
    Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, Etard JF, Pagnaroat M, Fournier-Nicolle I, Eholié S, Konate I, Minga A, Mpoudi-Ngole E, Koulla-Shiro S, Zannou DM, Anglaret X, Laurent C, ANRS 12222 Morbidity Mortality Study Group.
    J Acquir Immune Defic Syndr; 2013 Apr 15; 62(5):555-61. PubMed ID: 23274931
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.